Global Circulating Tumor Cells Market Insights, Forecast to 2029

Global Circulating Tumor Cells Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells Market Perspective (2018-2029)
2.2 Global Circulating Tumor Cells Growth Trends by Region
2.2.1 Circulating Tumor Cells Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Circulating Tumor Cells Historic Market Size by Region (2018-2023)
2.2.3 Circulating Tumor Cells Forecasted Market Size by Region (2024-2029)
2.3 Circulating Tumor Cells Market Dynamics
2.3.1 Circulating Tumor Cells Industry Trends
2.3.2 Circulating Tumor Cells Market Drivers
2.3.3 Circulating Tumor Cells Market Challenges
2.3.4 Circulating Tumor Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Circulating Tumor Cells by Players
3.1.1 Global Circulating Tumor Cells Revenue by Players (2018-2023)
3.1.2 Global Circulating Tumor Cells Revenue Market Share by Players (2018-2023)
3.2 Global Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Circulating Tumor Cells, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Circulating Tumor Cells Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells Revenue in 2022
3.5 Global Key Players of Circulating Tumor Cells Head office and Area Served
3.6 Global Key Players of Circulating Tumor Cells, Product and Application
3.7 Global Key Players of Circulating Tumor Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells Breakdown Data by Type
4.1 Global Circulating Tumor Cells Historic Market Size by Type (2018-2023)
4.2 Global Circulating Tumor Cells Forecasted Market Size by Type (2024-2029)
5 Circulating Tumor Cells Breakdown Data by Application
5.1 Global Circulating Tumor Cells Historic Market Size by Application (2018-2023)
5.2 Global Circulating Tumor Cells Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Circulating Tumor Cells Market Size (2018-2029)
6.2 North America Circulating Tumor Cells Market Size by Type
6.2.1 North America Circulating Tumor Cells Market Size by Type (2018-2023)
6.2.2 North America Circulating Tumor Cells Market Size by Type (2024-2029)
6.2.3 North America Circulating Tumor Cells Market Share by Type (2018-2029)
6.3 North America Circulating Tumor Cells Market Size by Application
6.3.1 North America Circulating Tumor Cells Market Size by Application (2018-2023)
6.3.2 North America Circulating Tumor Cells Market Size by Application (2024-2029)
6.3.3 North America Circulating Tumor Cells Market Share by Application (2018-2029)
6.4 North America Circulating Tumor Cells Market Size by Country
6.4.1 North America Circulating Tumor Cells Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Circulating Tumor Cells Market Size by Country (2018-2023)
6.4.3 North America Circulating Tumor Cells Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Circulating Tumor Cells Market Size (2018-2029)
7.2 Europe Circulating Tumor Cells Market Size by Type
7.2.1 Europe Circulating Tumor Cells Market Size by Type (2018-2023)
7.2.2 Europe Circulating Tumor Cells Market Size by Type (2024-2029)
7.2.3 Europe Circulating Tumor Cells Market Share by Type (2018-2029)
7.3 Europe Circulating Tumor Cells Market Size by Application
7.3.1 Europe Circulating Tumor Cells Market Size by Application (2018-2023)
7.3.2 Europe Circulating Tumor Cells Market Size by Application (2024-2029)
7.3.3 Europe Circulating Tumor Cells Market Share by Application (2018-2029)
7.4 Europe Circulating Tumor Cells Market Size by Country
7.4.1 Europe Circulating Tumor Cells Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Circulating Tumor Cells Market Size by Country (2018-2023)
7.4.3 Europe Circulating Tumor Cells Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Circulating Tumor Cells Market Size (2018-2029)
8.2 China Circulating Tumor Cells Market Size by Type
8.2.1 China Circulating Tumor Cells Market Size by Type (2018-2023)
8.2.2 China Circulating Tumor Cells Market Size by Type (2024-2029)
8.2.3 China Circulating Tumor Cells Market Share by Type (2018-2029)
8.3 China Circulating Tumor Cells Market Size by Application
8.3.1 China Circulating Tumor Cells Market Size by Application (2018-2023)
8.3.2 China Circulating Tumor Cells Market Size by Application (2024-2029)
8.3.3 China Circulating Tumor Cells Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Circulating Tumor Cells Market Size (2018-2029)
9.2 Asia Circulating Tumor Cells Market Size by Type
9.2.1 Asia Circulating Tumor Cells Market Size by Type (2018-2023)
9.2.2 Asia Circulating Tumor Cells Market Size by Type (2024-2029)
9.2.3 Asia Circulating Tumor Cells Market Share by Type (2018-2029)
9.3 Asia Circulating Tumor Cells Market Size by Application
9.3.1 Asia Circulating Tumor Cells Market Size by Application (2018-2023)
9.3.2 Asia Circulating Tumor Cells Market Size by Application (2024-2029)
9.3.3 Asia Circulating Tumor Cells Market Share by Application (2018-2029)
9.4 Asia Circulating Tumor Cells Market Size by Region
9.4.1 Asia Circulating Tumor Cells Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Circulating Tumor Cells Market Size by Region (2018-2023)
9.4.3 Asia Circulating Tumor Cells Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Type
10.2.1 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Circulating Tumor Cells Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Application
10.3.1 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Circulating Tumor Cells Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Country
10.4.1 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Menarini-Silicon Biosystems
11.1.1 Menarini-Silicon Biosystems Company Details
11.1.2 Menarini-Silicon Biosystems Business Overview
11.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Introduction
11.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2018-2023)
11.1.5 Menarini-Silicon Biosystems Recent Developments
11.2 Qiagen (Adnagen)
11.2.1 Qiagen (Adnagen) Company Details
11.2.2 Qiagen (Adnagen) Business Overview
11.2.3 Qiagen (Adnagen) Circulating Tumor Cells Introduction
11.2.4 Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2018-2023)
11.2.5 Qiagen (Adnagen) Recent Developments
11.3 Advanced Cell Diagnostics
11.3.1 Advanced Cell Diagnostics Company Details
11.3.2 Advanced Cell Diagnostics Business Overview
11.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Introduction
11.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2018-2023)
11.3.5 Advanced Cell Diagnostics Recent Developments
11.4 ApoCell
11.4.1 ApoCell Company Details
11.4.2 ApoCell Business Overview
11.4.3 ApoCell Circulating Tumor Cells Introduction
11.4.4 ApoCell Revenue in Circulating Tumor Cells Business (2018-2023)
11.4.5 ApoCell Recent Developments
11.5 Epic Sciences
11.5.1 Epic Sciences Company Details
11.5.2 Epic Sciences Business Overview
11.5.3 Epic Sciences Circulating Tumor Cells Introduction
11.5.4 Epic Sciences Revenue in Circulating Tumor Cells Business (2018-2023)
11.5.5 Epic Sciences Recent Developments
11.6 Greiner Bio-one GmbH
11.6.1 Greiner Bio-one GmbH Company Details
11.6.2 Greiner Bio-one GmbH Business Overview
11.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Introduction
11.6.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2018-2023)
11.6.5 Greiner Bio-one GmbH Recent Developments
11.7 Cynvenio
11.7.1 Cynvenio Company Details
11.7.2 Cynvenio Business Overview
11.7.3 Cynvenio Circulating Tumor Cells Introduction
11.7.4 Cynvenio Revenue in Circulating Tumor Cells Business (2018-2023)
11.7.5 Cynvenio Recent Developments
11.8 SurExamBio-Tech
11.8.1 SurExamBio-Tech Company Details
11.8.2 SurExamBio-Tech Business Overview
11.8.3 SurExamBio-Tech Circulating Tumor Cells Introduction
11.8.4 SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2018-2023)
11.8.5 SurExamBio-Tech Recent Developments
11.9 Fluxion Biosciences
11.9.1 Fluxion Biosciences Company Details
11.9.2 Fluxion Biosciences Business Overview
11.9.3 Fluxion Biosciences Circulating Tumor Cells Introduction
11.9.4 Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2018-2023)
11.9.5 Fluxion Biosciences Recent Developments
11.10 Ikonisys
11.10.1 Ikonisys Company Details
11.10.2 Ikonisys Business Overview
11.10.3 Ikonisys Circulating Tumor Cells Introduction
11.10.4 Ikonisys Revenue in Circulating Tumor Cells Business (2018-2023)
11.10.5 Ikonisys Recent Developments
11.11 Hangzhou Watson Biotech
11.11.1 Hangzhou Watson Biotech Company Details
11.11.2 Hangzhou Watson Biotech Business Overview
11.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Introduction
11.11.4 Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2018-2023)
11.11.5 Hangzhou Watson Biotech Recent Developments
11.12 Biocept
11.12.1 Biocept Company Details
11.12.2 Biocept Business Overview
11.12.3 Biocept Circulating Tumor Cells Introduction
11.12.4 Biocept Revenue in Circulating Tumor Cells Business (2018-2023)
11.12.5 Biocept Recent Developments
11.13 CytoTrack
11.13.1 CytoTrack Company Details
11.13.2 CytoTrack Business Overview
11.13.3 CytoTrack Circulating Tumor Cells Introduction
11.13.4 CytoTrack Revenue in Circulating Tumor Cells Business (2018-2023)
11.13.5 CytoTrack Recent Developments
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Details
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2018-2023)
11.14.5 Guangzhou Wondfo Biotech Recent Developments
11.15 Celsee
11.15.1 Celsee Company Details
11.15.2 Celsee Business Overview
11.15.3 Celsee Circulating Tumor Cells Introduction
11.15.4 Celsee Revenue in Circulating Tumor Cells Business (2018-2023)
11.15.5 Celsee Recent Developments
11.16 Clearbridge Biomedics
11.16.1 Clearbridge Biomedics Company Details
11.16.2 Clearbridge Biomedics Business Overview
11.16.3 Clearbridge Biomedics Circulating Tumor Cells Introduction
11.16.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2018-2023)
11.16.5 Clearbridge Biomedics Recent Developments
11.17 ANGLE plc
11.17.1 ANGLE plc Company Details
11.17.2 ANGLE plc Business Overview
11.17.3 ANGLE plc Circulating Tumor Cells Introduction
11.17.4 ANGLE plc Revenue in Circulating Tumor Cells Business (2018-2023)
11.17.5 ANGLE plc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Circulating Tumor Cells Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of CTC Enrichment
Table 3. Key Players of CTC Detection
Table 4. Key Players of CTC Analysis
Table 5. Global Circulating Tumor Cells Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Circulating Tumor Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Circulating Tumor Cells Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Circulating Tumor Cells Market Share by Region (2018-2023)
Table 9. Global Circulating Tumor Cells Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Circulating Tumor Cells Market Share by Region (2024-2029)
Table 11. Circulating Tumor Cells Market Trends
Table 12. Circulating Tumor Cells Market Drivers
Table 13. Circulating Tumor Cells Market Challenges
Table 14. Circulating Tumor Cells Market Restraints
Table 15. Global Circulating Tumor Cells Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Circulating Tumor Cells Revenue Share by Players (2018-2023)
Table 17. Global Top Circulating Tumor Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2022)
Table 18. Global Circulating Tumor Cells Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cells Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Circulating Tumor Cells, Headquarters and Area Served
Table 21. Global Key Players of Circulating Tumor Cells, Product and Application
Table 22. Global Key Players of Circulating Tumor Cells, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Circulating Tumor Cells Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Circulating Tumor Cells Revenue Market Share by Type (2018-2023)
Table 26. Global Circulating Tumor Cells Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Circulating Tumor Cells Revenue Market Share by Type (2024-2029)
Table 28. Global Circulating Tumor Cells Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Circulating Tumor Cells Revenue Share by Application (2018-2023)
Table 30. Global Circulating Tumor Cells Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Circulating Tumor Cells Revenue Share by Application (2024-2029)
Table 32. North America Circulating Tumor Cells Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Circulating Tumor Cells Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Circulating Tumor Cells Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Circulating Tumor Cells Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Circulating Tumor Cells Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Circulating Tumor Cells Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Circulating Tumor Cells Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Circulating Tumor Cells Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Circulating Tumor Cells Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Circulating Tumor Cells Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Circulating Tumor Cells Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Circulating Tumor Cells Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Circulating Tumor Cells Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Circulating Tumor Cells Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Circulating Tumor Cells Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Circulating Tumor Cells Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Circulating Tumor Cells Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Circulating Tumor Cells Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Circulating Tumor Cells Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Circulating Tumor Cells Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Circulating Tumor Cells Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Circulating Tumor Cells Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Circulating Tumor Cells Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Circulating Tumor Cells Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Circulating Tumor Cells Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Circulating Tumor Cells Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Circulating Tumor Cells Market Size by Country (2024-2029) & (US$ Million)
Table 64. Menarini-Silicon Biosystems Company Details
Table 65. Menarini-Silicon Biosystems Business Overview
Table 66. Menarini-Silicon Biosystems Circulating Tumor Cells Product
Table 67. Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 68. Menarini-Silicon Biosystems Recent Developments
Table 69. Qiagen (Adnagen) Company Details
Table 70. Qiagen (Adnagen) Business Overview
Table 71. Qiagen (Adnagen) Circulating Tumor Cells Product
Table 72. Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 73. Qiagen (Adnagen) Recent Developments
Table 74. Advanced Cell Diagnostics Company Details
Table 75. Advanced Cell Diagnostics Business Overview
Table 76. Advanced Cell Diagnostics Circulating Tumor Cells Product
Table 77. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 78. Advanced Cell Diagnostics Recent Developments
Table 79. ApoCell Company Details
Table 80. ApoCell Business Overview
Table 81. ApoCell Circulating Tumor Cells Product
Table 82. ApoCell Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 83. ApoCell Recent Developments
Table 84. Epic Sciences Company Details
Table 85. Epic Sciences Business Overview
Table 86. Epic Sciences Circulating Tumor Cells Product
Table 87. Epic Sciences Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 88. Epic Sciences Recent Developments
Table 89. Greiner Bio-one GmbH Company Details
Table 90. Greiner Bio-one GmbH Business Overview
Table 91. Greiner Bio-one GmbH Circulating Tumor Cells Product
Table 92. Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 93. Greiner Bio-one GmbH Recent Developments
Table 94. Cynvenio Company Details
Table 95. Cynvenio Business Overview
Table 96. Cynvenio Circulating Tumor Cells Product
Table 97. Cynvenio Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 98. Cynvenio Recent Developments
Table 99. SurExamBio-Tech Company Details
Table 100. SurExamBio-Tech Business Overview
Table 101. SurExamBio-Tech Circulating Tumor Cells Product
Table 102. SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 103. SurExamBio-Tech Recent Developments
Table 104. Fluxion Biosciences Company Details
Table 105. Fluxion Biosciences Business Overview
Table 106. Fluxion Biosciences Circulating Tumor Cells Product
Table 107. Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 108. Fluxion Biosciences Recent Developments
Table 109. Ikonisys Company Details
Table 110. Ikonisys Business Overview
Table 111. Ikonisys Circulating Tumor Cells Product
Table 112. Ikonisys Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 113. Ikonisys Recent Developments
Table 114. Hangzhou Watson Biotech Company Details
Table 115. Hangzhou Watson Biotech Business Overview
Table 116. Hangzhou Watson Biotech Circulating Tumor Cells Product
Table 117. Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 118. Hangzhou Watson Biotech Recent Developments
Table 119. Biocept Company Details
Table 120. Biocept Business Overview
Table 121. Biocept Circulating Tumor Cells Product
Table 122. Biocept Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 123. Biocept Recent Developments
Table 124. CytoTrack Company Details
Table 125. CytoTrack Business Overview
Table 126. CytoTrack Circulating Tumor Cells Product
Table 127. CytoTrack Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 128. CytoTrack Recent Developments
Table 129. Guangzhou Wondfo Biotech Company Details
Table 130. Guangzhou Wondfo Biotech Business Overview
Table 131. Guangzhou Wondfo Biotech Circulating Tumor Cells Product
Table 132. Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 133. Guangzhou Wondfo Biotech Recent Developments
Table 134. Celsee Company Details
Table 135. Celsee Business Overview
Table 136. Celsee Circulating Tumor Cells Product
Table 137. Celsee Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 138. Celsee Recent Developments
Table 139. Clearbridge Biomedics Company Details
Table 140. Clearbridge Biomedics Business Overview
Table 141. Clearbridge Biomedics Circulating Tumor Cells Product
Table 142. Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 143. Clearbridge Biomedics Recent Developments
Table 144. ANGLE plc Company Details
Table 145. ANGLE plc Business Overview
Table 146. ANGLE plc Circulating Tumor Cells Product
Table 147. ANGLE plc Revenue in Circulating Tumor Cells Business (2018-2023) & (US$ Million)
Table 148. ANGLE plc Recent Developments
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Circulating Tumor Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Circulating Tumor Cells Market Share by Type: 2022 VS 2029
Figure 3. CTC Enrichment Features
Figure 4. CTC Detection Features
Figure 5. CTC Analysis Features
Figure 6. Global Circulating Tumor Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Circulating Tumor Cells Market Share by Application: 2022 VS 2029
Figure 8. Breast Cancer Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Lung Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Circulating Tumor Cells Report Years Considered
Figure 14. Global Circulating Tumor Cells Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Circulating Tumor Cells Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Circulating Tumor Cells Market Share by Region: 2022 VS 2029
Figure 17. Global Circulating Tumor Cells Market Share by Players in 2022
Figure 18. Global Top Circulating Tumor Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Circulating Tumor Cells Revenue in 2022
Figure 20. North America Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Circulating Tumor Cells Market Share by Type (2018-2029)
Figure 22. North America Circulating Tumor Cells Market Share by Application (2018-2029)
Figure 23. North America Circulating Tumor Cells Market Share by Country (2018-2029)
Figure 24. United States Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Circulating Tumor Cells Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Circulating Tumor Cells Market Share by Type (2018-2029)
Figure 28. Europe Circulating Tumor Cells Market Share by Application (2018-2029)
Figure 29. Europe Circulating Tumor Cells Market Share by Country (2018-2029)
Figure 30. Germany Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Circulating Tumor Cells Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Circulating Tumor Cells Market Share by Type (2018-2029)
Figure 38. China Circulating Tumor Cells Market Share by Application (2018-2029)
Figure 39. Asia Circulating Tumor Cells Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Circulating Tumor Cells Market Share by Type (2018-2029)
Figure 41. Asia Circulating Tumor Cells Market Share by Application (2018-2029)
Figure 42. Asia Circulating Tumor Cells Market Share by Region (2018-2029)
Figure 43. Japan Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Circulating Tumor Cells Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Circulating Tumor Cells Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Circulating Tumor Cells Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Circulating Tumor Cells Market Share by Country (2018-2029)
Figure 53. Brazil Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Circulating Tumor Cells Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Menarini-Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 60. Qiagen (Adnagen) Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 61. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 62. ApoCell Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 63. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 64. Greiner Bio-one GmbH Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 65. Cynvenio Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 66. SurExamBio-Tech Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 67. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 68. Ikonisys Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 69. Hangzhou Watson Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 70. Biocept Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 71. CytoTrack Revenue Growth Rate in Circulating Tumor Cells Business (2018-2023)
Figure 72. Guangzhou Wondfo Biotech Revenue Growth Rate in Circulating Tumor Cells Business (2

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs